|
ADXN Addex Therapeutics Ltd - ADR 1574232 |
| Income Statement |
|
Net Income
|
2025-06-30
|
$-1,841,165.00 |
| Balance Sheet |
|
Current Assets
|
$2,657,580.00 |
|
Assets
|
$8,506,015.00 |
|
Current Liabilities
|
$1,150,446.00 |
|
Equity
|
$7,212,726.00 |
|
Shares Out
|
147831814.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-1,018,548.00 |
|
Investing Cash Flow
|
$-737,356.00 |
| Market Analysis |
Market Cap
|
$675,591,389.98 |
|
Price
|
$4.57 |
|
BVPS
|
0.05 |
|
PB
|
91.40 |
|
EPS
|
-9.44 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:33:01 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:51 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ADXN documents filed with the SEC.
ADXN Filings
Clear
